NCT06427096

Brief Summary

This is a 1:1 parallel design, multi-center, cluster-randomized control trial. A total of 80 villages in Ruyang County, Henan Province, China, will be randomly assigned to the intervention group or control group. At least 100 participants from 30-50 families in each village will be included in this study. The intervention group will engage in a variety of strategies, including educating a healthy lifestyle, adopting a low-sodium diet, managing weight, participating in physical exercise, monitoring blood pressure, and undergoing antihypertensive treatment. These efforts will be led by family health instructors from the community. The control group will receive usual care. The primary endpoint of this study is the change of systolic blood pressure from baseline to 6 months, reported as the difference between intervention and control group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8,001

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 18, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 23, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

May 23, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 12, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 28, 2025

Completed
Last Updated

March 4, 2026

Status Verified

March 1, 2026

Enrollment Period

9 months

First QC Date

May 18, 2024

Last Update Submit

March 2, 2026

Conditions

Keywords

cluster randomized trialblood pressurefamily interventionChina

Outcome Measures

Primary Outcomes (1)

  • The changes of systolic blood pressure from baseline to 6 months

    The systolic blood pressure changes from baseline to 6 months for all villagers, reported as the difference between intervention and control group.

    6 months

Secondary Outcomes (4)

  • The changes of systolic blood pressure from baseline to 12 months

    12 months

  • The changes of diastolic blood pressure from baseline to 6 months

    6 months

  • The proportion of participants with SBP<130 or DBP<80 mmHg at 6 months

    6 months

  • The proportion of participants with antihypertensive therapy at 6 months

    6 months

Study Arms (2)

Multifaceted intervention

EXPERIMENTAL

Residents in this group will receive multifaceted intervention including education for a healthy lifestyle, free provision of sodium substitute, weight management, physical exercise, BP monitoring, and appropriate antihypertensive treatment for individuals with hypertension.

Behavioral: Multifaceted intervention

Usual care

NO INTERVENTION

Residents in this group will receive usual lifestyle and health care management.

Interventions

The multifaceted interventions is comprised of the following components: 1. To establish a BP management team led by family health instructor. The team members also include family leaders and village doctors. 2. To conduct multifaceted intervention, which includes education for a healthy lifestyle, free provision of sodium substitute, weight management, physical exercise, BP monitoring, and appropriate antihypertensive treatment for individuals with hypertension.

Multifaceted intervention

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • At least one family member can use the smartphone to upload BP values.
  • Any family member participated in the other hypertension-related programs;
  • Inappropriate for the study decided by the healthy family instructor.
  • years old, regardless of BP level and antihypertensive treatment;
  • No travel plan for more than 1 month during the study period;
  • Written or fingerprinted informed consent form.
  • Significant cognitive dysfunction;
  • With advanced tumor, dialysis, or other serious diseases;
  • Lying in bed for a long time or unable to take care of themselves;
  • Diagnosed of secondary hypertension;
  • Having birth plans in the next six months, pregnant or lactating women;
  • Other ineligible circumstances judged by the investigators.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ruyang County People's Hospital

Luoyang, Henan, China

Location

Related Publications (1)

  • Tang Y, Jiang C, Guo J, Li Y, Wang C, Chu SH, Wang Z, Wu Y, Hua C, Lu Y, Zhang S, Song Y, Han R, Dong J, Ma C, Cai J, Anderson CS, Du X. Study protocol for the healthy family program on population blood pressure: A multicenter, parallel group, cluster randomized, controlled trial in rural China. Am Heart J. 2025 May;283:70-80. doi: 10.1016/j.ahj.2025.01.014. Epub 2025 Jan 28.

Study Officials

  • Jun Cai, MD

    Beijing Anzhen Hospital

    PRINCIPAL INVESTIGATOR
  • Xin Du, MD

    Beijing Anzhen Hospital

    PRINCIPAL INVESTIGATOR
  • Craig S Anderson, MD

    Institute of Science and Technology for Brain-Inspired Intelligence

    PRINCIPAL INVESTIGATOR
  • Chao Jiang, MD

    Beijing Anzhen Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 18, 2024

First Posted

May 23, 2024

Study Start

May 23, 2024

Primary Completion

February 12, 2025

Study Completion

July 28, 2025

Last Updated

March 4, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations